Stijn van Rompay
Fortuna: 38 M $ al 30/09/2026
Fortuna: 38 M $ al 30/09/2026
Stijn van Rompay was the founder of Uteron Pharma SA, founded in 2010, where the title held was General Manager from 2010 to 2015.
Mr. van Rompay is the founder of Hyloris Pharmaceuticals SA, founded in 2012, holding the title Chief Executive Officer & Executive Director starting in 2025.
Mr. van Rompay is also the founder of Alter Pharma Group NV.
Current jobs include Director at ImCyse SA since 2012, Managing Director & Director at EXO Biologics SA since 2019, and Managing Director & Director at Hyloris Developments SA since 2020.
Former jobs include Non-Executive Director at Coalesce Product Development Ltd. and Chief Financial Officer at Docpharma NV.
Education includes graduate degree from the University of Antwerp.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HYLORIS PHARMACEUTICALS SA 27,65 % | 31/03/2026 | 7.743.067 ( 27,65 % ) | 38 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HYLORIS PHARMACEUTICALS SA | Fundador | 01/01/2012 |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Director/Miembro de la Junta | 01/01/2012 |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company | Director/Miembro de la Junta | 29/08/2019 |
Hyloris Developments SA
Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Director Ejecutivo | 20/04/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
Coalesce Product Development Ltd.
Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Develops inhalation devices | Director/Miembro de la Junta | 27/09/2024 |
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Develops controlled release devices | Director Ejecutivo | 01/08/2015 |
Alter Pharma Group NV
Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Fundador | - |
Docpharma NV
Docpharma NV Pharmaceuticals: MajorHealth Technology Provides generic drugs | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Docpharma NV
Docpharma NV Pharmaceuticals: MajorHealth Technology Provides generic drugs | Health Technology |
University of Antwerp
University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Develops controlled release devices | Electronic Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Health Technology |
Alter Pharma Group NV
Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Hyloris Pharmaceuticals SA
Hyloris Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products by reformulating well-known drugs | Health Technology |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Coalesce Product Development Ltd.
Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Develops inhalation devices | Health Technology |
Hyloris Developments SA
Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.